CHMP adopts positive opinion recommending approval of new and expanded indications for SPEVIGO®
July 29, 2024 02:05 ET
|
Boehringer Ingelheim
The CHMP positive opinion is based on the EFFISAYIL® 2 trial, which showed that no flares were observed after week 4 of SPEVIGO® administered subcutaneously. During the 48-week trial, an 84% reduction...
Wolters Kluwer acquires accountancy portfolio of European cloud workflow automation and data exchange solutions
July 29, 2024 02:01 ET
|
Wolters Kluwer N.V.
PRESS RELEASE Wolters Kluwer acquires accountancy portfolio of European cloud workflow automation and data exchange solutions Acquisition includes CodaBox, ClearFacts, Clearnox,...
Das DynamX Sirolimus-Eluting Coronary Bioadaptor System von Elixir Medical erhält die FDA-Auszeichnung als bahnbrechendes Implantat
July 29, 2024 02:00 ET
|
Elixir Medical Corporation
Das DynamX Sirolimus-Eluting Coronary Bioadaptor System von Elixir Medical erhält die FDA-Auszeichnung als bahnbrechendes Implantat zur Behandlung symptomatischer ischämischer Herzkrankheit ...
Elixir Medical’s DynamX Sirolimus-Eluting coronary bioadaptor system receives US FDA Breakthrough Device Designation
July 29, 2024 02:00 ET
|
Elixir Medical Corporation
Elixir Medical's DynamX Sirolimus-Eluting Coronary Bioadaptor System Granted FDA Breakthrough Device Designation for the Treatment of Symptomatic Ischemic Heart Disease Designation recognizes the...
Transaction in own shares
July 29, 2024 02:00 ET
|
OSB GROUP PLC
OSB GROUP PLC ISIN: GB00BLDRH36029 July 2024 LEI number: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the “Company”) Transaction in Own Shares The Company announces...
Transaction in Own Shares
July 29, 2024 02:00 ET
|
PayPoint plc
29th July 2024 PayPoint plc ("PayPoint" or the "Company") Transaction in Own Shares The Company announces today it has purchased the following number of its ordinary shares of £0.00333 each...
EGIDE : Résultats du vote des résolutions présentées à l’Assemblée Générale Mixte du 25 juillet 2024
July 29, 2024 02:00 ET
|
EGIDE
Bollène, le 29 juillet 2024 – 8 :00 (CET) Communiqué de presse Résultats du vote des résolutions présentées à l’Assemblée Générale Mixte du 25 juillet 2024 La société Egide, (Euronext Growth Paris™-...
EssilorLuxottica annonce le lancement d’un programme de rachat d’actions
July 29, 2024 02:00 ET
|
EssilorLuxottica
EssilorLuxottica annonce le lancement d’un programme de rachat d’actions Paris, France (29 juillet 2024 – 8h00) – EssilorLuxottica annonce le lancement d’un programme de rachat d’actions, qui traduit...
EssilorLuxottica announces launch of share buyback program
July 29, 2024 02:00 ET
|
EssilorLuxottica
EssilorLuxottica announces launch of share buyback program Paris, France (July 29, 2024 – 08:00 am CEST) – EssilorLuxottica announces the launch of its share buyback program reflecting the Group’s...
Bedford Metals Receives Exploration Permit for Ubiquity Lake Uranium Project, Northern Saskatchewan
July 29, 2024 02:00 ET
|
Bedford Metals Corp.
Bedford Metals announces that it has received the necessary exploration permit for its 2024 prospecting program at the Ubiquity Lake Uranium Project